Title : Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5'-DFUR, the bioactive metabolite of Xeloda.

Pub. Date : 2012 May

PMID : 21915635






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5"-DFUR, the bioactive metabolite of Xeloda. 5"-dfur epidermal growth factor receptor Homo sapiens
2 Prior work in head and neck cancer showed that cell treatment with an inhibitor of the epidermal growth receptor (EGFR) gefitinib led to an increase in TP expression and sensitized them to 5"-DFUR. 5"-dfur epidermal growth factor receptor Homo sapiens